A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea

NCT03564119 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

372

Enrollment

INDUSTRY

Sponsor class

Conditions

Papulopustular Rosacea

Interventions

DRUG: S5G4T-1
DRUG: S5G4T-2

Sponsor

Sol-Gel Technologies, Ltd.